Fig. 4
From: Elevated exosome-derived miRNAs predict osimertinib resistance in non-small cell lung cancer
Osimertinib resistance induced by exosomal miRNAs targeting EGFR 21 mutations and T790M + patients. A q-PCR analysis of serum exosomal miR-184 and B miR-3913-5p expression levels in patients with drug resistance and sensitivity, in all patients with EGFR 19 exon deletion. C q-PCR analysis of serum exosomal miR-184 and D miR-3913-5p expression levels in patients with resistance and sensitivity in all patients with EGFR 19 exon L858R mutation